Skin penetration and kinetics of pristine fullerenes (C60) topically exposed in industrial organic solvents.

Pristine fullerenes (C60) in different solvents will be used in many industrial and pharmaceutical manufacturing and derivatizing processes. This report explores the impact of solvents on skin penetration of C60 from different types of industrial solvents (toluene, cyclohexane, chloroform and mineral oil). Yorkshire weanling pigs (n=3) were topically dosed with 500 microL of 200 microg/mL C60 in a given solvent for 24 h and re-dosed daily for 4 days to simulate the worst scenario in occupational exposures. The dose sites were tape-stripped and skin biopsies were taken after 26 tape-strips for quantitative analysis. When dosed in toluene, cyclohexane or chloroform, pristine fullerenes penetrated deeply into the stratum corneum, the primary barrier of skin. More C60 was detected in the stratum corneum when dosed in chloroform compared to toluene or cyclohexane. Fullerenes were not detected in the skin when dosed in mineral oil. This is the first direct evidence of solvent effects on the skin penetration of pristine fullerenes. The penetration of C60 into the stratum corneum was verified using isolated stratum corneum in vitro; the solvent effects on the stratum corneum absorption of C60 were consistent with those observed in vivo. In vitro flow-through diffusion cell experiments were conducted in pig skin and fullerenes were not detected in the receptor solutions by 24 h. The limit of detection was 0.001 microg/mL of fullerenes in 2 mL of the receptor solutions.

[1]  R. Bronaugh,et al.  Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. , 1985, Journal of pharmaceutical sciences.

[2]  N. Monteiro-Riviere,et al.  Assessment of Quantum Dot Penetration into Intact, Tape-Stripped, Abraded and Flexed Rat Skin , 2008, Skin Pharmacology and Physiology.

[3]  J. James,et al.  Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  R. Fenske.  Dermal exposure assessment techniques. , 1993, The Annals of occupational hygiene.

[5]  Jenny R. Roberts,et al.  Skin as a route of exposure and sensitization in chronic beryllium disease. , 2003, Environmental health perspectives.

[6]  J. Hadgraft.  Skin, the final frontier. , 2001, International journal of pharmaceutics.

[7]  William W. Yu,et al.  Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. , 2008, Toxicology and applied pharmacology.

[8]  Nancy A Monteiro-Riviere,et al.  Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. , 2007, Nano letters.

[9]  José Juan Escobar-Chávez,et al.  The tape-stripping technique as a method for drug quantification in skin. , 2008, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[10]  B. Idson.  Vehicle effects in percutaneous absorption. , 1983, Drug metabolism reviews.

[11]  J. Nierengarten,et al.  Fullerenes : principles and applications , 2007 .

[12]  Stephen R. Wilson.  Nanomedicine: Fullerene and Carbon Nanotube Biology , 2002 .

[13]  Y. Kalia,et al.  Characterization of the permeability barrier of human skin in vivo. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Nancy A. Monteiro-Riviere,et al.  Nanotoxicology : characterization, dosing and health effects , 2007 .

[15]  J E Riviere,et al.  Interspecies and interregional analysis of the comparative histologic thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species. , 1990, The Journal of investigative dermatology.

[16]  Mark D. Hoover,et al.  Exposure Assessment Considerations for Nanoparticles in the Workplace , 2007 .

[17]  M. Harper.  Assessing workplace chemical exposures: the role of exposure monitoring. , 2004, Journal of environmental monitoring : JEM.

[18]  R. L. Anderson,et al.  Variations in Physical Dimensions and Chemical Composition of Human Stratum Corneum , 1973 .

[19]  Paul Schulte,et al.  Occupational Risk Management of Engineered Nanoparticles , 2008, Journal of occupational and environmental hygiene.

[20]  T. Ghosh,et al.  Transdermal and Topical Drug Delivery Systems , 2004, Theory and Practice of Contemporary Pharmaceutics.

[21]  J. Riviere,et al.  Predicting skin permeability from complex chemical mixtures. , 2005, Toxicology and applied pharmacology.

[22]  P. Gershkovich,et al.  A review of the application of lipid-based systems in systemic, dermal/ transdermal, and ocular drug delivery. , 2008, Critical reviews in therapeutic drug carrier systems.

[23]  M. Roberts,et al.  Veterinary drug delivery: potential for skin penetration enhancement. , 2001, Advanced drug delivery reviews.

[24]  B. F. V. Duzee.  Thermal Analysis Of Human Stratum Corneum , 1975 .

[25]  H. Fenniri,et al.  Nanotechnology-based drug delivery systems , 2007, Journal of occupational medicine and toxicology.

[26]  M. López-Quintela,et al.  Penetration of metallic nanoparticles in human full-thickness skin. , 2007, The Journal of investigative dermatology.

[27]  J E Riviere,et al.  Percutaneous absorption of parathion in vitro in porcine skin: effects of dose, temperature, humidity, and perfusate composition on absorptive flux. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[28]  N. Monteiro-Riviere,et al.  Penetration of intact skin by quantum dots with diverse physicochemical properties. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  P. Hoet,et al.  Nanoparticles – known and unknown health risks , 2004, Journal of nanobiotechnology.

[30]  M. Prabhakaran,et al.  Nanotechnology for nanomedicine and delivery of drugs. , 2008, Current pharmaceutical design.

[31]  M. Roberts,et al.  Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety , 2007, Critical reviews in toxicology.

[32]  Hari Singh Nalwa,et al.  Nanotechnology and health safety--toxicity and risk assessments of nanostructured materials on human health. , 2007, Journal of nanoscience and nanotechnology.

[33]  T. Franz,et al.  Vehicle effects on percutaneous absorption: in vivo and in vitro comparisons with human skin , 1986, The British journal of dermatology.

[34]  H. Benson,et al.  Transdermal drug delivery: penetration enhancement techniques. , 2005, Current drug delivery.

[35]  Brian W. Barry,et al.  Dermatological Formulations: Percutaneous Absorption , 1983 .

[36]  H. Maibach,et al.  Physical and physiological effects of stratum corneum tape stripping , 2001, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[37]  E. Ōsawa.  Perspectives of Fullerene Nanotechnology , 2002 .

[38]  R. L. Anderson,et al.  Hydration of stratum corneum , 1973, Biopolymers.

[39]  N. Monteiro-Riviere,et al.  Trace analysis of fullerenes in biological samples by simplified liquid-liquid extraction and high-performance liquid chromatography. , 2006, Journal of chromatography. A.